|
| 6.1 - 11.1 | 7.8 - 10.0 | P | logistics |
| n | 415 | 177 |
|
|
| Age, median [Q1, Q3] | 55.00 [44.00, 65.00] | 57.00 [47.00, 66.00] | 0.100 | 0.122 |
| Male, n | 249 | 105 | 0.927 | / |
| Male, (%) | 60.00% | 59.32% | ||
| ethnicity |
|
|
|
|
| white, n | 256 | 109 |
|
|
| white, (%) | 61.69% | 61.58% |
|
|
| BLACK/AFRICAN AMERICAN, n | 51 | 25 |
|
|
| BLACK/AFRICAN AMERICAN, (%) | 12.29% | 14.12% |
|
|
| AMERICAN INDIAN/ALASKA NATIVE, n | 2 | 0 |
|
|
| AMERICAN INDIAN/ALASKA NATIVE, (%) | 0.48% | 0.00% |
|
|
| PORTUGUESE, n | 4 | 0 |
|
|
| PORTUGUESE, (%) | 0.96% | 0.00% |
|
|
| UNKNOWN, n | 50 | 20 |
|
|
| UNKNOWN, (%) | 12.05% | 11.30% |
|
|
| ASIAN, n | 12 | 4 |
|
|
| ASIAN, (%) | 2.89% | 2.26% |
|
|
| OTHER, n | 16 | 7 |
|
|
| OTHER, (%) | 3.86% | 3.95% |
|
|
| HISPANIC/LATINO, n | 13 | 5 |
|
|
| HISPANIC/LATINO, (%) | 3.13% | 2.82% |
|
|
| UNABLE TO OBTAIN, n | 11 | 7 |
|
|
| UNABLE TO OBTAIN, (%) | 2.65% | 3.95% |
|
|
| Aps III, median [Q1, Q3] | 62.00 [43.00, 87.50] | 64.00 [47.00, 89.00] | 0.228 | / |
| inSOFA, median [Q1, Q3] | 1.00 [0, 4.00] | 1.00 [0, 4.00] | 0.680 | / |
| ▲SOFA, median [Q1, Q3] | 1.00 [−1.00, 3.00] | 1.00 [0, 3.00] | 0.600 | / |
| Glu_meana (mmol/L), median [Q1, Q3] | 7.88 [7.00, 8.92] | 8.56 [8.18, 9.18] | <0.001* | / |
| Glu_cvb, median [Q1, Q3] | 0.23 [0.17, 0.33] | 0.26 [0.20, 0.37] | 0.005 | 0.254 |
| Glu_frequency* (n/day), median [Q1, Q3] | 4.59 [3.63, 6.34] | 5.14 [4.19, 7.35] | 0.002 | 0.222 |
| LOS in ICUc, median [Q1, Q3] | 5.83 [3.14, 13.74] | 5.96 [3.11, 14.05] | 0.944 | / |
| LOS in hospitald, median [Q1, Q3] | 17.76 [9.99, 28.95] | 18.13 [8.83, 28.88] | 0.792 | / |
| antibiotic day, median [Q1, Q3] | 1.00 [0, 3.00] | 1.00 [0, 3.00] | 0.407 | / |
| die, n | 204 | 89 | 0.858 | / |
| die, (%) | 49.16% | 50.28% | ||
| blood-infection, n | 123 | 55 | 0.769 | / |
| blood-infection, (%) | 29.64% | 31.07% | ||
| Abdominal-infection, n | 60 | 24 | 0.898 | / |
| Abdominal-infection, (%) | 14.46% | 13.56% | ||
| urinary-infection, n | 45 | 22 | 0.573 | / |
| urinary-infection, (%) | 10.84% | 12.43% | ||
| respiratory-infection, n | 71 | 29 | 0.905 | / |
| respiratory-infection, (%) | 17.11% | 16.38% | ||
| diabetes, n | 135 | 82 | 0.002 | 0.043 |
| diabetes, (%) | 32.53% | 46.33% | ||
| hypoglycemia, n | 7 | 2 | 1.000 | / |
| hypoglycemia, (%) | 2.81% | 1.90% | ||
| die, n | 62 | 36 | 0.1167 | / |
| die, (%) | 14.94% | 20.34% | ||
| hyperlipidemia, n | 85 | 47 | 0.107 | / |
| hyperlipidemia, (%) | 34.14% | 44.76% |